[go: up one dir, main page]

WO2011015796A3 - Combination of a visible radiation and a peptide agent increasing the expression of a substrate of cytochrome c oxidase, in particular for improving the appearance of the skin and/or hair - Google Patents

Combination of a visible radiation and a peptide agent increasing the expression of a substrate of cytochrome c oxidase, in particular for improving the appearance of the skin and/or hair Download PDF

Info

Publication number
WO2011015796A3
WO2011015796A3 PCT/FR2010/051670 FR2010051670W WO2011015796A3 WO 2011015796 A3 WO2011015796 A3 WO 2011015796A3 FR 2010051670 W FR2010051670 W FR 2010051670W WO 2011015796 A3 WO2011015796 A3 WO 2011015796A3
Authority
WO
WIPO (PCT)
Prior art keywords
cytochrome
oxidase
substrate
visible radiation
hair
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2010/051670
Other languages
French (fr)
Other versions
WO2011015796A2 (en
Inventor
Julien Laboureau
Quang Lan Nguyen
Dang-Man Pham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of WO2011015796A2 publication Critical patent/WO2011015796A2/en
Anticipated expiration legal-status Critical
Publication of WO2011015796A3 publication Critical patent/WO2011015796A3/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/81—Preparation or application process involves irradiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention more specifically relates to a cosmetic treatment method, in particular for improving the appearance of the skin and/or hair, including simultaneously and/or consecutively administering: at least one peptide agent increasing the expression of at least one substrate of cytochrome C oxidase, and optionally at least one substrate of cytochrome C oxidase; and at least one visible radiation having a predominant wavelength activating the cytochrome C oxidase. In particular, said visible radiation has at least one predominant wavelength activating the cytochrome C oxidase of 550 to 1000 nm, in particular 550 to 800 nm, preferably 620 to 700 nm, and most preferably 640 to 680 nm, and is preferably used at a dose of 0.01 to 200 J/cm2, preferably 0.1 to 30 J/cm2, more preferably 1 to 30 J/cm2, or even 5 to 30 J/cm2. The invention also relates to a composition and to a kit.
PCT/FR2010/051670 2009-08-07 2010-08-06 Combination of a visible radiation and a peptide agent increasing the expression of a substrate of cytochrome c oxidase, in particular for improving the appearance of the skin and/or hair Ceased WO2011015796A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US23216709P 2009-08-07 2009-08-07
FR0903906A FR2948876B1 (en) 2009-08-07 2009-08-07 ASSOCIATION OF LUMINOUS RADIATION AND A PEPTIDE AGENT INCREASING THE EXPRESSION OF A CYTOCHROME C OXIDASE SUBSTRATE TO IMPROVE THE APPEARANCE OF THE SKIN AND / OR THE HAIR
FR0903906 2009-08-07
US61/232,167 2009-08-07

Publications (2)

Publication Number Publication Date
WO2011015796A2 WO2011015796A2 (en) 2011-02-10
WO2011015796A3 true WO2011015796A3 (en) 2012-10-26

Family

ID=42174542

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2010/051670 Ceased WO2011015796A2 (en) 2009-08-07 2010-08-06 Combination of a visible radiation and a peptide agent increasing the expression of a substrate of cytochrome c oxidase, in particular for improving the appearance of the skin and/or hair

Country Status (2)

Country Link
FR (1) FR2948876B1 (en)
WO (1) WO2011015796A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2951947B1 (en) * 2009-11-03 2022-01-07 Isp Investments Inc USE OF A COMPOSITION COMPRISING AN UNFERMENTED RICE PEPTIDE EXTRACT TO STIMULATE HAIR GROWTH
US11253721B2 (en) * 2018-12-07 2022-02-22 Seoul Viosys Co., Ltd. LED lighting apparatus having sterilizing function
FR3095658B1 (en) 2019-05-02 2022-09-16 Laboratoires Danjou Cosmetic care process based on photoactive extracts of microalgae

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB990082A (en) * 1962-01-16 1965-04-22 David Agnew Vogel Cosmetical and therapeutic compositions
FR2589728A1 (en) * 1985-11-12 1987-05-15 Cotta Portella Fernando Process for obtaining a concentrate of annatto (Bixa orellana seeds) which can be used as an agent for screening actinic radiation, and sun protection composition based on this concentrate
EP1090628A1 (en) * 1999-10-07 2001-04-11 L'oreal Use of lycopene in compositions for treating ageing skin symptoms
WO2003001984A2 (en) * 2001-06-29 2003-01-09 Light Bioscience, Inc. Method and apparatus for the photomodulation of living cells
US20030212388A1 (en) * 2002-05-13 2003-11-13 Ronn Avigdor M. Treatment of localized pain with a flexible conformational array of light
WO2004075985A2 (en) * 2003-02-26 2004-09-10 Photo Therapeutics Ltd. Cosmetic or therapeutic methods and apparatus
FR2915393A1 (en) * 2007-04-27 2008-10-31 Vincience Sa PHARMACEUTICAL AND / OR COSMETIC COMPOSITION CONTAINING CYTOCHROME C ACTIVE ACTIVATOR
FR2915382A1 (en) * 2007-04-27 2008-10-31 Vincience Sa Use of an active ingredient obtained from hydrolyzed maize, in a cosmetic composition or for preparing a pharmaceutical composition comprising the active ingredient or composition to activate cytochrome c and stimulate mitochondria
FR2915385A1 (en) * 2007-04-27 2008-10-31 Vincience Sa USE OF AN ACTIVE INGREDIENT FROM AMARANTE (AMARANTHUS) FOR PREPARING A COMPOSITION FOR ACTIVATING CELL ENERGY AND PROTECTING THE SKIN FROM OXIDATIVE DAMAGE.
FR2915381A1 (en) * 2007-04-27 2008-10-31 Vincience Sa Use of an active ingredient obtained from hydrolyzed soy, in a cosmetic composition or for preparing a pharmaceutical composition comprising the ingredient or composition to activate cytochrome and stimulate mitochondrion
FR2915380A1 (en) * 2007-04-27 2008-10-31 Vincience Sa Use of active ingredient obtained from hydrolyzed rice, in a cosmetic composition or for preparing pharmaceutical composition comprising active ingredient or composition to activate cytochrome and protect mitochondrion
WO2008145854A1 (en) * 2007-04-27 2008-12-04 Societe D'extraction Des Principes Actifs S.A. (Isp Vincience) Pharmaceutical and/or cosmetic composition containing peptides
FR2917299A1 (en) * 2007-06-15 2008-12-19 Danielle Roches Sarl Wrinkles cosmetic treatment method for skin, involves exposing skin area to source emitting light whose wavelength spectrum is in between specific nanometer and light intensity of specific millicandela during predetermined period
FR2926985A1 (en) * 2008-02-06 2009-08-07 Oreal COMBINATION OF LIGHT RADIATION AND A CYTOCHROME C OXIDASE SUBSTRATE TO IMPROVE IN PARTICULAR THE APPEARANCE OF THE SKIN AND / OR HAIR

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR758017A (en) 1932-07-07 1934-01-09 Budd Edward G Mfg Co Bodywork refinements
GB9406142D0 (en) 1994-03-28 1994-05-18 British Tech Group A sensor

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB990082A (en) * 1962-01-16 1965-04-22 David Agnew Vogel Cosmetical and therapeutic compositions
FR2589728A1 (en) * 1985-11-12 1987-05-15 Cotta Portella Fernando Process for obtaining a concentrate of annatto (Bixa orellana seeds) which can be used as an agent for screening actinic radiation, and sun protection composition based on this concentrate
EP1090628A1 (en) * 1999-10-07 2001-04-11 L'oreal Use of lycopene in compositions for treating ageing skin symptoms
WO2003001984A2 (en) * 2001-06-29 2003-01-09 Light Bioscience, Inc. Method and apparatus for the photomodulation of living cells
US20030212388A1 (en) * 2002-05-13 2003-11-13 Ronn Avigdor M. Treatment of localized pain with a flexible conformational array of light
WO2004075985A2 (en) * 2003-02-26 2004-09-10 Photo Therapeutics Ltd. Cosmetic or therapeutic methods and apparatus
FR2915393A1 (en) * 2007-04-27 2008-10-31 Vincience Sa PHARMACEUTICAL AND / OR COSMETIC COMPOSITION CONTAINING CYTOCHROME C ACTIVE ACTIVATOR
FR2915382A1 (en) * 2007-04-27 2008-10-31 Vincience Sa Use of an active ingredient obtained from hydrolyzed maize, in a cosmetic composition or for preparing a pharmaceutical composition comprising the active ingredient or composition to activate cytochrome c and stimulate mitochondria
FR2915385A1 (en) * 2007-04-27 2008-10-31 Vincience Sa USE OF AN ACTIVE INGREDIENT FROM AMARANTE (AMARANTHUS) FOR PREPARING A COMPOSITION FOR ACTIVATING CELL ENERGY AND PROTECTING THE SKIN FROM OXIDATIVE DAMAGE.
FR2915381A1 (en) * 2007-04-27 2008-10-31 Vincience Sa Use of an active ingredient obtained from hydrolyzed soy, in a cosmetic composition or for preparing a pharmaceutical composition comprising the ingredient or composition to activate cytochrome and stimulate mitochondrion
FR2915380A1 (en) * 2007-04-27 2008-10-31 Vincience Sa Use of active ingredient obtained from hydrolyzed rice, in a cosmetic composition or for preparing pharmaceutical composition comprising active ingredient or composition to activate cytochrome and protect mitochondrion
WO2008145854A1 (en) * 2007-04-27 2008-12-04 Societe D'extraction Des Principes Actifs S.A. (Isp Vincience) Pharmaceutical and/or cosmetic composition containing peptides
FR2917299A1 (en) * 2007-06-15 2008-12-19 Danielle Roches Sarl Wrinkles cosmetic treatment method for skin, involves exposing skin area to source emitting light whose wavelength spectrum is in between specific nanometer and light intensity of specific millicandela during predetermined period
FR2926985A1 (en) * 2008-02-06 2009-08-07 Oreal COMBINATION OF LIGHT RADIATION AND A CYTOCHROME C OXIDASE SUBSTRATE TO IMPROVE IN PARTICULAR THE APPEARANCE OF THE SKIN AND / OR HAIR

Also Published As

Publication number Publication date
FR2948876A1 (en) 2011-02-11
FR2948876B1 (en) 2011-11-04
WO2011015796A2 (en) 2011-02-10

Similar Documents

Publication Publication Date Title
EA200901555A1 (en) LOCAL APPLICATION COMPOSITION FOR SKIN CARE AND TREATMENT METHOD
WO2009074735A8 (en) Use of a novel natural agent in cosmetic compositions
WO2010095118A3 (en) A cosmetic treatment method including the projection of an image onto the zone to be treated
WO2007089454A3 (en) Methods for enhancing skin treatments
WO2009050506A3 (en) Combination 059
EP2759302A3 (en) 4F-benzoyl-TN14003 combined with rituximab for use in the treatment of a tumour
WO2006116731A3 (en) Personal care compositions comprising a dipeptide
WO2007129270A3 (en) Cosmetic compositions comprising at least one peptide with at least one immobilized aromatic cycle
WO2008010167A3 (en) Treatment articles capable of delivering intensive care and overall treatment simultaneously
PT2210588E (en) Foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin
WO2006087759A3 (en) Pharmaceutical composition comprising curcumin and resveratrol and uses thereof in medical field
MX2010004877A (en) Multistep cosmetic compositions.
WO2006053332A3 (en) Treatment articles capable of conforming to an underlying shape
WO2012116990A3 (en) Novel use
WO2008107092A3 (en) Use of derivatives of 4-hydroxyphenoxy acetic acid
WO2007078857A3 (en) Use of non-straight fibers dispersed in a composition and compositions thereof
WO2012076109A3 (en) 2-pyrones
WO2008043900A3 (en) Use of a cosmetic composition for the care of fatty skin
WO2009112763A3 (en) Combination of a light ray and a lipase-bioconvertible compound for improving skin and/or hair appearance
WO2005102010A3 (en) Personal care compositions that deposit sunless tanning benefit agents
WO2005094554A3 (en) Therapeutic agents, methods, and treatments
WO2007130501A3 (en) Combination therapy for treatment of cancer
WO2011015796A3 (en) Combination of a visible radiation and a peptide agent increasing the expression of a substrate of cytochrome c oxidase, in particular for improving the appearance of the skin and/or hair
WO2006018454A3 (en) Cosmetic preparation comprising hyaluronic acid and saponins for treatment of skin aging phenomena
PT1809383E (en) Cosmetic compositions

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10762733

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10762733

Country of ref document: EP

Kind code of ref document: A2